文献速递基础与转化研究新药、器械与细胞基因治疗研发

基因治疗改善溶酶体贮积症小鼠模型中的肠道动力障碍和肠神经元变性并延长生存期

Gene therapy ameliorates bowel dysmotility and enteric neuron degeneration and extends survival in lysosomal storage disorder mouse models.
PubMed 文献 · Sci Transl Med · 2025-01-15

研究在神经元蜡样脂褐质沉积症1型和2型(CLN1和CLN2)小鼠模型中观察到肠道传输减慢且随年龄加重,伴肌间丛神经元进行性丢失和肠胶质细胞改变,CLN1病患儿结肠尸检也见类似病理。新生期腺相关病毒介导的基因治疗可预防肠道传输缺陷、改善肠神经元丢失并延长小鼠生存,断奶后治疗仍可延长CLN1小鼠寿命但效果不及新生期治疗。

要点

  • CLN1和CLN2小鼠均出现随年龄加重的肠道传输减慢及肌间丛神经元进行性丢失。
  • CLN1病患儿结肠尸检可见类似肠神经系统病理改变。
  • 新生期基因治疗可预防肠道传输缺陷、改善肠神经元丢失并延长生存;断奶后治疗仍延长CLN1小鼠寿命但效果较弱。

核心结论

  • 数据提供两种溶酶体贮积症中存在肠神经系统变性的原理验证证据,并提示基因治疗可改善肠神经系统病变且提高生存率。

研究设计与样本

  • 研究评估了CLN1和CLN2疾病小鼠模型,两种疾病分别由棕榈酰蛋白硫酯酶-1和三肽基肽酶-1缺陷引起。
  • 研究对小鼠进行在体肠道传输评估,并分析肠神经系统及成年小鼠肌间丛神经元和肠胶质细胞。
  • 研究分析了1例CLN1病患儿结肠尸检材料,并测试了新生期及断奶后经腺相关病毒介导的基因治疗。

主要发现

  • 两种小鼠品系在体均显示肠道传输减慢,且随年龄增长而加重。
  • 这些小鼠肠神经系统发育看似正常,但成年小鼠出现进行性且严重的肌间丛神经元丢失,伴肠胶质细胞改变。
  • 1例CLN1病患儿结肠尸检材料中可见类似病理。
  • 新生期给予腺相关病毒介导的基因治疗可预防肠道传输缺陷、改善肠神经元丢失并延长小鼠生存期。
  • 断奶后治疗的效果不及新生期治疗,但仍延长了CLN1疾病小鼠的寿命。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Children with neurodegenerative disease often have debilitating gastrointestinal symptoms. We hypothesized that this may be due at least in part to underappreciated degeneration of neurons in the enteric nervous system (ENS), the master regulator of bowel function. To test this hypothesis, we evaluated mouse models of neuronal ceroid lipofuscinosis type 1 and 2 (CLN1 and CLN2 disease, respectively), neurodegenerative lysosomal storage disorders caused by deficiencies in palmitoyl protein thioesterase-1 and tripeptidyl peptidase-1, respectively. Both mouse lines displayed slow bowel transit in vivo that worsened with age. Although the ENS appeared to develop normally in these mice, there was a progressive and profound loss of myenteric plexus neurons accompanied by changes in enteric glia in adult mice. Similar pathology was evident in colon autopsy material from a child with CLN1 disease. Neonatal administration of adeno-associated virus-mediated gene therapy prevented bowel transit defects, ameliorated loss of enteric neurons, and extended survival in mice. Treatment after weaning was less effective than treating neonatally but still extended the lifespan of CLN1 disease mice. These data provide proof-of-principle evidence of ENS degeneration in two lysosomal storage diseases and suggest that gene therapy can ameliorate ENS disease, also improving survival.

来源:Sci Transl Med,查看原文。版权归原作者所有。

引用

  1. Ziółkowska EA, Jansen MJ, Williams LL, et al. Gene therapy ameliorates bowel dysmotility and enteric neuron degeneration and extends survival in lysosomal storage disorder mouse models. Sci Transl Med. 2025. PMID: 39813314. doi:10.1126/scitranslmed.adj1445

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。